Subscribe: Best Syndication - Prostate Cancer
Added By: Feedage Forager Feedage Grade B rated
Language: English
cancer  news  prostate cancer  prostate  radiation therapy  read  risk  study  syndication news  syndication  therapy  treatment 
Rate this Feed
Rate this feedRate this feedRate this feedRate this feedRate this feed
Rate this feed 1 starRate this feed 2 starRate this feed 3 starRate this feed 4 starRate this feed 5 star

Comments (0)

Feed Details and Statistics Feed Statistics
Preview: Best Syndication - Prostate Cancer

Best Syndication - Prostate Cancer


Low Oxygen in Cells might spur Cancer Growth

Fri, 04 May 2012 05:08:39 +0000


(Best Syndication News) - The tumor growth rate of certain cancers could be increased with low oxygen levels, according to recent study from researchers at the University of Georgia. The study was published in the early online edition of the Journal of Molecular Cell Biology.

The current consensus of most researchers is that genetic mutation is the main cause of cancer growth. This study suggests another cause: low oxygen levels (hypoxia) in cells. Oxygen may play a role in unruly tumor growth in certain types of cancer. Prior research showed that low oxygen levels were a contributing factor to cause cancer to advance, however, they did not point to it as the main cause.

read more

2012 California County Health Report released by CDPH

Thu, 12 Apr 2012 22:07:25 +0000


(Best Syndication News) - The California Department of Public Health has released their County Health Status Profiles 2012 report that assesses the health status of each county throughout the state. The current data analyzed was between 2008 – 2010 and was compared against the Healthy People 2010 National Objectives to determine if the state has met each goal.

The CDPH report saw improvements from the previous report that involved the years of 2005 through 2007. The new report saw around a 14 percent decline in the birthrates of adolescent mothers for the 2008 through 2010 data. There was a 29.4 percent reduction in motor vehicle traffic crash death rates, which was the best improvement overall in the 2012 report. The rates of Gonorrhea infections declined by 25.6 percent. AIDS infections declined by 24.4 percent. Diabetes death rates also showed a decline by 11.1 percent. All cancers including lung, breast, and prostate declined since the 2005 – 2007 report. There also was a reduction in coronary heart disease, and cerebrovascular disease. However, death rates for Alzheimer’s disease and suicide rates increased.

read more

Daily Aspirin Regimen might be beneficial for Preventing Cancer

Tue, 10 Apr 2012 03:30:04 +0000


(Best Syndication News) - The American Cancer Society has released a new report that suggests aspirin may play a part in reducing the risk for death from cancer. The new information may one day lead to medical professional recommending aspiring for cancer prevention. The report was published online in Nature Reviews Clinical Oncology.

Previous research has suggested that taking a daily aspirin could reduce the risk for colorectal cancer and the recurrence of adenomatous polyps. There is a downfall in taking aspirin for bleeding risk. However, a study of cardiovascular trials found that taking 75-100 mg daily also reduced the cancer risk for all types.

read more

Medivation Shares rise after Positive Results from Prostate Drug Trial

Thu, 02 Feb 2012 09:51:56 +0000


(Best Syndication News) –Medivation, Inc. (NASDAQ: MDVN) shares increased 21.95 percent, up $12.16 to close at $67.57. The share price climbed Wednesday, after of positive results with the Phase 3 AFFIRM trial for a drug to treat prostate cancer. Medivation is working with Japan based Astellas Pharma Inc. (TYO: 4503) on the development of the MDV3100 investigational drug.

Data from the trial showed that MDV3100 provided an average 4.8 month life extension compared to the placebo group. The data will be presented at the 2012 Genitourinary Cancers Symposium in San Francisco, CA this Thursday, February 2.

read more

Dr. Andrew Weil shares Alternative Medicine Therapies on ‘The Dr. Oz Show’

Sat, 02 Jul 2011 05:04:55 +0000


(Best Syndication News) - Dr. Andrew Weil was a guest on today's ‘The Dr. Oz Show.’ He came on the TV show to listed some foods that help reduce inflammation. He also shared on supplements, foods, and products that could protect the brain, lungs, and heart. Dr. Weil is an author or several books including, "8 Weeks to Optimum Health: A Proven Program for Taking Full Advantage of Your Body's Natural Healing Power."

Dr. Andrew Weil is a physician. He said that he did not learn prevention in medical school. When he was getting older, he was not feeling so well, so he started to learn alternative medicinal treatments. He stopped eating meat, started meditating among other things, which had made him feel better. During his investigation into medicinal treatments worldwide, he found many great cures and some that were nonsense. When he shared what he learned with his colleagues, they did not share his enthusiasm. He calls the combined traditional medicine with alternative treatments and therapies integrated medicine. Dr. Weil’s integrated medicine will help people to learn to eat better and to handle stress. Dr. Weil explained that he hopes one day they drop the word integrative and just call it good medicine.

read more

Prostate Cancer Vaccine used to cured mice in Mayo Clinic Study

Sun, 19 Jun 2011 20:24:25 +0000


(Best Syndication News) - A study from the Mayo Clinic and several UK research institutions revealed that a human vaccine treatment was able to cure mice with prostate tumors. The vaccine for prostate cancer did not show any discernible side effects. They wanted to see if the immune system's own resources, along with the vaccine, could be used to purge prostate tumors from the body. The hope is to develop a new medical treatment that would not involve any toxic chemotherapy or radiation treatments.

Richard Vile, Ph.D., a Mayo Clinic immunologist, professor from the Richard M. Schulze Family Foundation and lead author of the study, said the researchers hope to begin clinical trials in two years.

read more

Doctor Oz Discusses The Biggest Lies about Cancer on his Dr Oz Show

Fri, 17 Jun 2011 11:39:02 +0000


(Best Syndication News) Doctor Mehmet C Oz told his studio audience that they may be worried for the wrong reasons on Thursday’s show. There are some myths concerning cancer and he wanted to set the record straight.

Cancer is the second leading cause of death. He said that the doctors aren’t telling the lies, but we are “telling each other’.

Big Lie #1: You Don’t Have Cancer

“We all have microscopic cancers growing inside of us all of the time,” Dr William Li, MD, a cancer researcher and pioneer, told Oz. There are 50 trillion cells in our body and all it takes is one cell to mutate.

Our immune system fights these cells every day. Also, our body naturally prevents blood vessels from growing into and feeding cancers.

read more

Prostate Cancer Survival Rates Extended with Surgery

Sun, 15 May 2011 20:57:54 +0000


(Best Syndication News) Researchers say that advanced prostate cancer patients who undergo radical prostatectomy can experience 20-year survival rates. Doctors are getting better at determining surgery candidates.

"We are doing a much better job of identifying and expanding candidates for surgery, which results in better, longer outcomes for so many of our patients," says R. Jeffrey Karnes, M.D., of Mayo Clinic's Department of Urology.

There are various stages and grades of prostate cancer. Stage cT3 prostate cancer has spread beyond the prostate. Currently, patients with cT3 prostate cancer are typically given radiation or hormone treatment only. But this may change.

read more

Dr Oz Discusses Foods that Fight Cancer

Mon, 09 May 2011 02:26:34 +0000


(Best Syndication News) When people eat food they typically think about the calories, but they should also think about the cancer prevention benefits of the food too. On Thursday Dr. Oz told his audience that certain foods can help prevent cancer.

The National Institutes of Health (NIH) found studies that support some of the claims made on the Dr Oz show. Men who ate carotenoid lycopene, which is found in tomatoes, could reduce their risk of some of the more deadly forms of prostate cancer. “Five studies support a 30% to 40% reduction in risk associated with high tomato or lycopene consumption”, the NIH concluded.

read more

Metastatic Prostate Cancer – Zytiga medication (abiraterone acetate) gets FDA approval

Sat, 30 Apr 2011 20:03:14 +0000


(Best Syndication News) - The US Food and Drug Administration (FDA) approved Zytiga (abiraterone acetate) medication along with prednisone (a steroid) for the treatment of late-stage metastatic prostate cancer. Zytiga is marketed by Centocor Ortho Biotech Inc.

Zytiga is a once daily pill that helps to decrease testosterone levels in those patients that have not been able to with other treatments. The abirateron acetate drug targets a protein called cytochrome P450 17A1 (CYP17A1), which is known to create the testosterone hormone. By reducing the hormones it would slow the cancer cell growth.

Zytiga gained FDA approval ahead of the June 20, 2011 regulatory goal date. The clinical study of 1,195 patients that had late-stage castration-resistant prostate cancer and also had previously received treatment with docetaxel chemotherapy were studied with either Zytiga one per day along with prednisone twice each day or the other group was given a placebo (sugar pill) two times per day along with the prednisone treatment.

read more

Growth Hormone might not be Fountain of Youth Anti-aging Remedy

Thu, 23 Dec 2010 23:17:03 +0000


Photo courtesy CDC/ James Gathany PD

(Best Syndication News) - According to recent study, the exact opposite an “un-growth” hormone showed anti-aging potential. The compound is called MZ-5-156 and is a growth hormone-releasing hormone (GHRH) antagonist. The study results were published in the online December 6th edition of the National Academy of Sciences.

John E. Morley, M.D., study co-investigator and director of the divisions of geriatric medicine and endocrinology at Saint Louis University School of Medicine said that older people taking growth hormone supplements to reverse aging may actually “be hazardous”.

The researchers studied a SAMP8 mouse model for aging and they discovered that the MZ-5-156 had showed a beneficial outcome for oxidative stress in the brain. This helped the mice have better cognition and the telomerase activity was improved. The mice also had an increased life span while at the same time decreasing the amount of tumors. The MZ-5-156 also has been found in other research to repress prostate, breast, brain and lung cancer in humans. In addition there has been research that have measured improvement on short-term memory and improved learning. In this study, the MZ-5-156 created an antioxidant action that reduced oxidative stress and reversed cognitive damage in the mice as they aged.

read more

Patients with Inoperable Prostate Cancer Found To Be Free Of Disease After Treatment From Mayo Clinic

Sat, 20 Jun 2009 01:25:00 +0000


Before and After - source: Mayo Clinic

(Best Syndication News) Unexpectedly, two patients suffering from inoperable prostate cancer survived after doctors administered a new treatment followed by surgery. Not only are they surviving, according to researchers at the Mayo Clinic in Minnesota, they are “cancer free”. The doctors can not detect any cancer in their bodies.

After being diagnosed with inoperable prostate cancer in California, Roger Nelson and his wife traveled back to Minnesota for treatment. Roger was made aware of an experimental therapy. This therapy was thought to be his best option and he opted for it.

read more

Prostate Cancer Test Could Save Lives – Discovery of Molecules Could Lead To Identification and Treatment

Thu, 12 Feb 2009 08:01:16 +0000


Prostate Cancer Tissue - source: wi

(Best Syndication News) A new test may help doctors determine how aggressive a patient’s prostate cancer is. Researchers at the University of Michigan Comprehensive Cancer Center have identified a panel of small molecules, or metabolites, that can be used to help decide treatment options. One of the metabolites, sarcosine, was a better indicator of advancing cancer than the traditional prostate specific antigen (PSA) test (see video below).

Some cases of prostate cancer are over treated while others may be under treated. “We end up overtreating our patients because physicians don’t know which tumors will be slow-growing. With this research, we have identified a potential marker for the aggressive tumors,” says senior study author Arul Chinnaiyan, M.D., Ph.D.

read more

Tests for Different Possible Cancers

Wed, 19 Nov 2008 21:28:42 +0000


Best Syndication News

If cancer is a possibility, it is your doctor’s responsibility to order the necessary tests to accurately and quickly diagnose your cancer. The faster your cancer is diagnosed, the more quickly you can begin treatment and increase your chance of survival. Here are some tests that should be run if you suspect cancer:

Skin cancer

If your doctor thinks you have melanoma, he or she should take a biopsy from the area around the melanoma and send it to a pathology lab for analysis. If your biopsy shows melanoma, you may need to have more tests, like another biopsy or a lymph node dissection to determine whether the cancer has spread to your lymph nodes.

Breast cancer

read more

Do men with prostate cancer who undergo surgery need radiation therapy, too?

Tue, 15 Apr 2008 16:06:22 +0000


Dr. Kornmehl

There are a number of treatment options for men with prostate cancer. These include a surgical procedure, known as radical prostatectomy, as well as radiation therapy. Are there any situations wherein a man who undergoes a radical prostatectomy will need radiation therapy afterwards?

The answer is yes, in special circumstances. Such radiation therapy is known as salvage radiotherapy, and is advisable for men whose PSA levels rise after surgery, as well as for those whose PSA levels never fully decline. The reason is that radiation therapy can increase the odds of survival for such men.

A recent study reviewed the data of 635 men with rising PSA levels after radical prostatectomy. In the study, 160 of the men received salvage radiation therapy, 78 received salvage radiation therapy and hormonal therapy (which lowers the level of prostate cancer stimulating male hormones in the blood stream), and 397 received no treatment.

read more

Lipitor And Celebrex Effective Treatment For Prostate Cancer – Slows Progression In Early And Later Stages

Tue, 15 Apr 2008 03:08:49 +0000


Lipitor and Celebrex For Prostate Cancer

(Best Syndication) The combination of two widely used drugs may slow the progression of prostate cancer, according to researchers at the Rutgers’ Ernest Mario School of Pharmacy. Lipitor used in conjunction with Celebrex “stops the transition” from early prostate cancer to the more aggressive later stages.

This is important news because prostate cancer is usually diagnosed in the early stages and it is the second leading cause of cancer death in men in the United States. The findings were revealed on Monday at the annual meeting of the American Association for Cancer Research in San Diego.

read more

Commonly used Drugs may have Additional Benefits for Men with Prostate Cancer

Fri, 14 Mar 2008 15:42:25 +0000


stock photo

A new study of more than 7,000 men suggests that those with localized prostate cancer (which means the disease hasn't spread beyond the prostate gland) who take cholesterol reducing statin drugs or anti-inflammatory agents live longer than men who don't use these medications.

Some of the well known statins include Zocor, Lipitor, Pravachol, Crestor, Lescol, and Mevacor. Commonly used anti-inflammatory drugs include aspirin, ibuprofen (Motrin, Advil), and naproxen (Aleve).

Statins, Anti-Inflammatory Drugs and Prostate Cancer

The study evaluated men who were diagnosed with prostate cancer between 1990 and 2003. Nearly 65% underwent surgery to remove the prostate gland, while the remainder underwent radiation therapy. Both treatments are highly effective for treating localized prostate cancer.

read more

Cancer Death Rate On Decline – 2005 Numbers Actually Higher, But Actual Rate Lower Than 2004

Thu, 21 Feb 2008 01:40:48 +0000


Stock Photo

(Best Syndication) The cancer death rate in the United States is still declining, according to a report form the American Cancer Society. The mortality rate is down 18.4 percent among men and 10.5 percent among women since the mortality rate began falling in the 1990s. The 2005 data is now in.

Although there was an actual increase in the number of deaths (5,424 more deaths than the previous year), because of the population increase, the rate has declined. There were 559,312 cancer deaths in 2005 compared to 553,888 cancer deaths in 2004. The Cancer Society expects there to be 565,650 cancer deaths in 2008 (294,120 among men and 271,530 among women).

read more

Interactions of Aspirin and Hormonal Therapy in Men with Prostate Cancer

Tue, 05 Feb 2008 19:15:35 +0000


stock photo

Prostate cancer is a common diagnosis in men, especially in the older population. Other medical problems, such as heart disease, are also frequent in this age group.

Hormone therapy is a helpful treatment for many men with prostate cancer and aspirin is protective for those with heart disease. Since many of these men are diagnosed with both heart disease and prostate cancer, it seems intuitive that they should take both aspirin and hormone therapy.

Hormone therapy reduces the blood level of testosterone, the male hormone that prostate cancer cells tend to thrive on. Aspirin, on the other hand, is a blood thinner that helps to prevent blood clots and heart attacks. In addition, hormonal therapy can raise a man’s risk of having a heart attack, so taking baby aspirin seems like a sensible approach to decrease this possibility.

read more

Prostate Cancer Risk associated with Fatherhood

Mon, 07 Jan 2008 22:41:32 +0000


stock photo

[Best Syndication] Men that do not have children seem to have a reduced risk for developing prostate cancer when compared with those that have become fathers. There was an exception that the more children that he fathered, the risk for developing prostate cancer was reduced again. The study was first published in the February 15th, issue of CANCER which is published by the American Cancer Society.

The study was conducted by Kristian Jørgensen of the Statens Serum Institut, in Copenhagen, Denmark. The data was analyzed from men born in Denmark from 1935 through 1988. There were a total of 3,400 that developed prostate cancer. Men without children had a 16 percent reduced chance of developing compared with those that had children. The researchers point out that the risk for prostate cancer reduced as the number of children increased.

read more